Colon News and Research

RSS

New oral gel used instead of injection to deliver drugs

Scientists in India have developed a new gel that is taken orally and is capable of delivering drugs to manage diseases often requiring an injection.

20 Sep 2004

Cancer survivors' other medical problems poorly managed

People who survive cancer are less likely to receive necessary care for a wide range of other non-cancer-related medical problems according to a new study published September 13, 2004 in the online edition of CANCER, a peer- reviewed journal of the American Cancer Society.

12 Sep 2004

Gene mutations cause 85 percent of colon cancers

Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.

9 Sep 2004

Cancers, including colon, prostate, and leukemia, continue to grow unchecked

Many cancers, including colon, prostate, and leukemia, continue to grow unchecked because they do not respond to a signal to die and stop proliferating from Transforming Growth Factor-beta (TGF-b).

8 Sep 2004

Men's magazines don’t inform men about prostate and colon cancer screening

Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men’s magazines.

8 Sep 2004

CT scans may be delivering as much radiation as a low-dose atomic bomb

Those full-body CT scans advertised at some health care centers may be delivering as much radiation as a low-dose atomic bomb, according to a new study. And that means people who get them could be raising their cancer risk, researchers from Columbia University report in the journal Radiology (Vol. 232, No. 3:735-738).

5 Sep 2004

Research provides definitive evidence that radiation risk is associated with full-body CT scans

The risk of cancer mortality from a single full-body computed tomography (CT) scan is modest, but not negligible, and the risks resulting from elective annual scans are much higher, according to a study published in the September issue of the journal Radiology.

31 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

New database about a group of genes associated with multidrug resistance in cancerous tumors

Scientists at the National Cancer Institute, have created a database of information about a group of genes associated with multidrug resistance in cancerous tumors.

23 Aug 2004

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

23 Aug 2004

60 percent of people with Crohn's disease have required surgery within the past five years

According to results released today from the newest survey of people with Crohn's disease, "Voices of Crohn's," 60 percent of people with Crohn's, between the ages of 18 and 34, have been hospitalized within the last two years and more than half have required surgery within the past five years.

18 Aug 2004

New colon cancer guidelines

The American Society of Clinical Oncology has developed a set of recommendations to address whether patients who have had successful surgery for Stage II colon cancer should be offered adjuvant chemotherapy in routine clinical practice.

17 Aug 2004

Physicians today perform more colonoscopies than necessary

A colonoscopy allows a physician look inside the entire large intestine, from the lowest part, the rectum, all the way up through the colon to the lower end of the small intestine.

16 Aug 2004

New blood test to detect ovarian cancer

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

16 Aug 2004

Blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease

Their preliminary studies with the new test suggest a molecular signature exclusive to this deadly cancer, known for its ability to remain undetected and spread quickly.

15 Aug 2004

World's first tagatose-containing chocolate is very low in glycemic load

Spherix Incorporated today announced that the world's first tagatose-containing chocolate, Miada(R) ChocoLite(R), is very low in Glycemic Load (GL) and estimated relative Glycemic Index (GI), according to newly performed studies.

13 Aug 2004

Bionomics BNO69 angiogenesis gene discovery published

Bionomics has announced that research conducted by Bionomics and its collaborators at the Hanson Centre of the Institute of Medical and Veterinary Science ("IMVS") in Adelaide, Australia, relating to Bionomics' proprietary angiogenesis drug target BNO69, has been published in the high ranking scientific journal Proceedings of the National Academy of Sciences USA (PNAS).

10 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

New pill-size camera travels beyond other scope procedures to reveal gastrointestinal disorders in small intestines that often go unseen

If it doesn't sound like your typical disposable camera, that's because it's not. And while this new camera is not designed to snap shots during vacations or at other special occasions, patients are finding that the latest in high-tech, digital photography is very easy to swallow.

9 Aug 2004

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Acrongenomics Inc. has introduced a revolutionary design of its nanobiotechnology product, the Neo-EpCAM(TM) cancer detection kit, which fuses molecular diagnostics with nanotechnology.

29 Jul 2004